Study and Microbiologic Analysis of Klebsiella spp. Isolated from Urinary Tract Infections Clinical Samples in Kirkuk City
Studi dan Analisis Mikrobiologi Klebsiella spp. yang Diisolasi dari Sampel Klinis Infeksi Saluran Kemih di Kota Kirkuk
DOI:
https://doi.org/10.21070/ijhsm.v2i2.128Keywords:
Klebsiella pneumonia, Phenotypic Identification, Urinary Tract Infections (UTIs), Biochemical Tests.Abstract
Background: Klebsiella pneumoniae is a prevalent cause of urinary tract infections (UTIs), which are a serious issue of public health. Since K. pneumoniae strains are developing increasing resistance to antibiotics, prompt and precise diagnosis is necessary for successful treatment. Aim: The purpose of this study was to separate and recognize K. pneumoniae from UTI patients' samples of urine. Additionally, it aimed to assess the efficacy of several diagnostic techniques, such as Vitek 2, biochemical, and phenotypic. Method: The study, which included both governmental and commercial healthcare facilities, was carried out in Kirkuk province, Iraq, between January and October of 2024. Urine samples were taken from 90 UTI patients, representing both sexes and an extensive range of age groups. The study used various diagnostic techniques. For initial identification, phenotypic and biochemical testing were conducted. The automated Vitek 2 system provides quick and precise identification. Results: 33.4% of the urine samples had K. pneumoniae. The age range of 5 to 25 years old had the highest prevalence, and girls were more likely than males to have it. All of the diagnostic methods used in the investigation were successful in confirming every isolate. Conclusion: The study concluded that K. pneumoniae had a major role in the investigated group's UTIs. The results stress the importance of utilizing a variety of techniques for diagnosis in order to accurately and promptly identify this disease, This is necessary for both infection prevention and successful treatment.
Highlights:
- pneumoniae increasingly causes UTIs and resists antibiotic treatment.
- Urine samples tested using phenotypic, biochemical, and Vitek 2 methods.
- 4% positive; young females most affected; all methods effective..
Keywords: Klebsiella pneumonia, Phenotypic Identification, Urinary Tract Infections (UTIs), Biochemical Tests.
References
[1] M. Gajdács, M. Ábrók, A. Lázár, and K. Burián, “Increasing Relevance of Gram-Positive Cocci in Urinary Tract Infections: A 10-Year Analysis of Their Prevalence and Resistance Trends,” Scientific Reports, vol. 10, no. 1, p. 17658, Oct. 2020, doi: 10.1038/s41598-020-74834-y.
[2] H. Sakkas, P. Bozidis, A. Ilia, G. Mpekoulis, and C. Papadopoulou, “Antimicrobial Resistance in Bacterial Pathogens and Detection of Carbapenemases in Klebsiella pneumoniae Isolates from Hospital Wastewater,” Antibiotics, vol. 8, no. 3, p. 85, 2019.
[3] I. T. Abdullah, F. A. Hasib, and F. I. Mohammad, “Studying the Prevalence of Multidrug Resistant Klebsiella pneumoniae in Kirkuk City,” NTU Journal of Agriculture and Veterinary Science, vol. 3, no. 4, 2023.
[4] R. Abbas et al., “General Overview of Klebsiella pneumoniae: Epidemiology and the Role of Siderophores in Its Pathogenicity,” Biology, vol. 13, no. 2, p. 78, 2024.
[5] T. Bermudez, J. E. Schmitz, M. Boswell, and R. Humphries, “Novel Technologies for the Diagnosis of Urinary Tract Infections,” Journal of Clinical Microbiology, vol. 63, no. 2, e00306-24, Feb. 2025, doi: 10.1128/jcm.00306-24.
[6] S. A. H. Mohammed, N. B. Mahdi, and H. S. Akbar, “Sensitivity of Klebsiella pneumoniae Bacteria Isolated from the Urine of Patients with Urinary Tract Infections in Kirkuk City/Iraq,” 2024.
[7] J. L. Dombach et al., “Antimicrobial Susceptibilities of Clinical Bacterial Isolates from Urinary Tract Infections to Fosfomycin and Comparator Antibiotics,” Microbiology Spectrum, vol. 13, no. 3, e01860-24, Mar. 2025, doi: 10.1128/spectrum.01860-24.
[8] M. Palacios et al., “Identification of Two Regulators of Virulence That Are Conserved in Klebsiella pneumoniae Classical and Hypervirulent Strains,” *mBio*, vol. 9, e01443-18, 2018, doi: 10.1128/mBio.01443-18.
[9] A. M. Parrott et al., “Detection of Multiple Hypervirulent *Klebsiella pneumoniae* Strains in a New York City Hospital Through Screening of Virulence Genes,” Clinical Microbiology and Infection, vol. 27, no. 4, pp. 583–589, Apr. 2021, doi: 10.1016/j.cmi.2020.05.012.
[10] A. Karagöz, S. Acar, and H. Körkoca, “Characterization of Klebsiella Isolates by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and Determination of Antimicrobial Resistance with VITEK 2 AES,” Turkish Journal of Medical Sciences, vol. 45, no. 6, pp. 1335–1344, 2015.
[11] I. Nakasone et al., “Laboratory-Based Evaluation of the Colorimetric VITEK-2 Compact System for Species Identification and Detection of Antimicrobial Resistances,” Diagnostic Microbiology and Infectious Disease, vol. 58, no. 2, pp. 191–198, 2007, doi: 10.1016/j.diagmicrobio.2006.12.008.
[12] H. Chandra et al., “Promising Roles of Alternative Medicine and Plant-Based Nanotechnology as Remedies for Urinary Tract Infections,” Molecules, vol. 25, no. 23, p. 5593, Nov. 2020, doi: 10.3390/molecules25235593.
[13] M. A. M. Al-Mousawi and W. A. H. Al-Daraghi, “Molecular Detection of Klebsiella pneumoniae and Its Relationship With Multidrug Resistance Isolated from Clinical Samples,” Biochemical and Cellular Archives, vol. 22, no. 1, 2022.
[14] A. O. Ozgen and O. E. Eyupoglu, “Antibiotic Susceptibility of Klebsiella pneumoniae* Strains Isolated from Clinical Samples,” Journal of the Turkish Chemical Society, Section A: Chemistry*, vol. 7, pp. 319–326, 2020, doi: 10.18596/jotcsa.635088.
[15] V. Vandhana et al., “Characterization of Hypervirulent Klebsiella pneumoniae (Hv-Kp): Correlation of Virulence with Antimicrobial Susceptibility,” International Journal of Microbiology, 2022.
[16] S. N. A. Al-Jubouri and S. N. Dahham, “Isolating and Identification of Some Types of Bacteria That Cause Otitis Media and Detecting Their Resistance Towards Antibiotics,” University of Kirkuk Journal of Science, vol. 18, no. 4, 2023.
[17] Y. Mouanga-Ndzime et al., “Trends in Escherichia coli and Klebsiella pneumoniae Urinary Tract Infections and Antibiotic Resistance Over a 5-Year Period in Southeastern Gabon,” Antibiotics, vol. 14, no. 1, p. 14, 2024, doi: 10.3390/antibiotics14010014.
[18] A. A. J. Aljanaby and H. M. R. J. Alhasnawi, “Phenotypic and Molecular Characterization of Multidrug Resistant Klebsiella pneumoniae Isolated from Different Clinical Sources in Al-Najaf Province-Iraq,” *Pakistan Journal of Biological Sciences*, vol. 20, no. 5, pp. 217–232, 2017.
[19] M. Edham and N. Kamel, “Bacteriological and Physiological Study of Bacterial Infection of the Blood Stream,” Tikrit Journal of Pure Science, vol. 23, pp. 20–25, Aug. 2018, doi: 10.25130/tjps.v23i8.538.
[20] T. A. Hafiz et al., “Klebsiella pneumoniae Bacteraemia Epidemiology: Resistance Profiles and Clinical Outcome of King Fahad Medical City Isolates, Riyadh, Saudi Arabia,” BMC Infectious Diseases, vol. 23, no. 1, p. 579, 2023, doi: 10.1186/s12879-023-08563-8.
[21] K. I. A. Al-Masoudi, H. S. O. Al-Janabi, and H. T. M. Al-Mousawi, “Isolation and Characterization of Klebsiella pneumoniae from Urinary Tract Infections: A Comparative Study of Diagnostic Methods,” *SAR Journal of Pathology and Microbiology*, vol. 6, no. 1, pp. 1–7, 2025.
[22] K. Gupta et al., “International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases,” Clinical Infectious Diseases, vol. 52, pp. e103–e120, 2011.
[23] E. S. Huang and R. S. Stafford, “National Patterns in the Treatment of Urinary Tract Infections in Women by Ambulatory Care Physicians,” Archives of Internal Medicine, vol. 162, pp. 41–47, 2002.
[24] S. D. Advani et al., “Optimizing Reflex Urine Cultures: Using a Population-Specific Approach to Diagnostic Stewardship,” Infection Control and Hospital Epidemiology, vol. 44, pp. 206–209, 2023, doi: 10.1017/ice.2022.315.
[25] Z. Sheng et al., “Clinical and Microbiological Characteristics of Klebsiella pneumoniae Bloodstream Infection in a Chinese Hospital: Hypervirulent and Multiclonal,” Infection and Drug Resistance, vol. 15, pp. 3981–3990, 2022.
[26] C. Shankar et al., “Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae,” Frontiers in Cellular and Infection Microbiology, vol. 11, p. 709681, 2021.
[27] J. E. Choby, J. Howard-Anderson, and D. S. Weiss, “Hypervirulent Klebsiella pneumoniae—Clinical and Molecular Perspectives,” Journal of Internal Medicine, vol. 287, pp. 283–300, 2020.
[28] T. M. Coque, A. Oliver, J. C. Pérez-Díaz, F. Baquero, and R. Cantón, “Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended-Spectrum Beta-Lactamases Are Carried by Multiple Klebsiella pneumoniae Clones in a Single Hospital (Madrid, 1989 to 2000),” Antimicrobial Agents and Chemotherapy, vol. 46, pp. 500–510, 2002, doi: 10.1128/AAC.46.2.500-510.2002.
